REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Profile Updated: May 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd is a company located in Nanjing. It was listed on the Shanghai Stock Exchange on July 19, 2017. The company specializes in the production of isolators and high-end sterile injectables. It has a global quality system that is certified in multiple regions including China, the United States, Europe, Japan, and Brazil. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd has a strong focus on research and development, a global quality awareness, and sales capabilities rooted in the United States. Additionally, the company offers contract development and manufacturing organization (CDMO) services for injectables, with a core focus on the Chinese and American markets. Recently, the company established a new division for innovative biopharmaceuticals, aiming to attract global talent and drive innovation and internationalization, with the goal of becoming a world-class biopharmaceutical company.

Headquarters
No. 16, Xuefu Road, High-tech Industrial Development Zone, Nanjing, Jiangsu Province
Nanjing; Jiangsu; Postal Code: 210061

Contact Details: Purchase the Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd report to view the information.

Website: http://www.nkf-pharma.com

Basic Information
Total Employees:
Purchase the Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd report to view the information.
Registered Capital:
Purchase the Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd report to view the information.
Financial Auditors:
Purchase the Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd report to view the information.
Incorporation Date:
October 16, 2000
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Standing Deputy General Manager
Ownership Details
Purchase this report to view the information.
27.2%
Purchase this report to view the information.
21.25%
Purchase this report to view the information.
19.79%
Purchase this report to view the information.
4.37%
Purchase this report to view the information.
1.98%
Subsidiaries
Hong Kong Jianyou Industrial Co., Ltd.
100%
Kinjin Pharmaceutical Co., Ltd.
100%
Kongnan co., ltd.
100%
Company Performance
Financial values in the chart are available after Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-23.19%
Total operating revenue
-23.6%
Operating profit (EBIT)
-47.62%
EBITDA
-47.42%
Net Profit (Loss) for the Period
-46.68%
Total assets
-10.31%
Total equity
-8.01%
Operating Profit Margin (ROS)
-9.23%
Net Profit Margin
-7.78%
Return on Equity (ROE)
-2.15%
Debt to Equity Ratio
-14%
Quick Ratio
0.01%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?